- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 403/04 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
Patent holdings for IPC class C07C 403/04
Total number of patents in this class: 13
10-year publication summary
|
1
|
0
|
3
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
4 |
| BASF SE | 21334 |
1 |
| DSM IP Assets B.V. | 5395 |
1 |
| The Board of Regents of the University of Oklahoma | 666 |
1 |
| Golden Biotechnology Corporation | 33 |
1 |
| Katra Phytochem (India) Private Limited | 10 |
1 |
| Myongji University Industry and Academia Cooperation Foundation | 219 |
1 |
| Suzhou Miracpharma Technology Co., Ltd. | 31 |
1 |
| Yuhan Corporation | 244 |
1 |
| Merck Sharp & Dohme LLC | 3734 |
1 |
| Other owners | 0 |